Testosterone for women
Testosterone is used off-label for low sexual desire in postmenopausal women. No FDA-approved product for women exists in the US.
How it works
Testosterone levels in women decline gradually through the reproductive years and drop further around menopause. Low testosterone is associated with reduced sexual desire (hypoactive sexual desire disorder, HSDD), low energy, and reduced sense of wellbeing. The 2019 Global Consensus Statement on Women's Testosterone recognized testosterone as an evidence-based treatment for HSDD in postmenopausal women — the strongest evidence base is for sexual desire specifically, not for general energy or mood. There are no FDA-approved testosterone products for women in the US; physicians prescribe compounded testosterone creams or gels, or use male-formulated products at much lower fractions of the labeled dose.
Because compounded testosterone lacks FDA oversight of potency and purity, batch-to-batch variability is a real concern. Monitoring via blood levels (total and free testosterone) is recommended to ensure levels are within the premenopausal female reference range — supraphysiologic levels increase the risk of androgenic side effects. Side effects at appropriate doses are generally mild: acne, oily skin, increased body hair, or clitoral sensitivity. At supraphysiologic doses, more significant virilization can occur.
How to track Testosterone for women
- Sexual desire and satisfaction — the indication with the strongest evidence base; log separately from other libido-adjacent factors.
- Energy and sense of wellbeing — commonly reported benefits, but harder to attribute specifically to testosterone vs. other HRT components.
- Androgenic side effects: acne, oily skin, body hair changes, or clitoral sensitivity — dose-related and should be logged with timing.
- Blood testosterone level test dates and results — essential for monitoring that levels stay within the premenopausal female reference range.
- Application site and consistency for compounded products — absorption varies with formulation, site, and skin condition.
- Rate sexual desire on a consistent scale before starting and throughout treatment — the clinical trial evidence for testosterone is specifically for desire, and your log quantifies whether that benefit is occurring.
- Log blood testosterone test dates alongside symptom data — monitoring lab values is a required part of off-label testosterone use, and your symptom and lab records belong together.
- Track androgenic side effects (acne, hair changes) with dates and severity — they are the leading indicator that levels may be supraphysiologic.
- If using a compounded product, log the product name, pharmacy, concentration, and any batch changes — compounding variability is a real factor in response consistency.
- Separate energy and wellbeing tracking from sexual desire tracking — they may respond on different timelines and have different dose-response relationships.
Questions to ask your physician
- My pre-treatment sexual desire rating was [X]. At [N] weeks on testosterone, my current rating is [Y]. Is that response consistent with the evidence base for HSDD treatment?
- My latest testosterone blood level was [X] on [date]. Is that within the premenopausal female reference range, and does it align with my symptom response?
- I've been logging androgenic side effects (acne, hair changes) at [severity] since [date] — does that pattern suggest my dose is higher than needed?
- My energy and wellbeing log shows [pattern] alongside testosterone use — is that a recognized effect at my dose level, or more likely attributable to other HRT components?